BioTie Therapies Corp. Has Filed Registration Statement For U.S. Public Offering

Biotie Has Filed Registration Statement for U.S. Public Offering

In accordance with its previously announced plans, Biotie Therapies Corp. (“Biotie”) has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to its proposed U.S. public offering of American Depositary Shares, representing Biotie’s ordinary shares (“ADSs”). The number of ADSs to be offered and the price range for the offering have not yet been determined. Biotie has made an initial submission to list its ADSs on the NASDAQ Global Market under the ticker symbol “BITI”.

RBC Capital Markets and Stifel are acting as joint book-running managers. JMP Securities is acting as lead manager and Roth Capital Partners is acting as a co-manager.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This stock exchange release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus related to the offering may be obtained from: RBC Capital Markets, LLC, 200 Vesey Street, 8th Floor, New York, New York 10281, attn.: Equity Syndicate Department, or by calling +1 877 822 4089, or by emailing equityprospectus@rbccm.com, or from Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, by telephone at +1 415 364 2720 or by email at syndprospectus@stifel.com.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC